September 18, 2026

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unveiling a 24.41% Upside Potential in the Healthcare Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialized player in the healthcare sector, is capturing investor attention with its promising portfolio focused on rare disease treatments. Based..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a Potential 62.78% Upside

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with a promising outlook for investors...

Septerna, Inc. (SEPN) Investor Outlook: Strong Buy Ratings Signal 37% Potential Upside

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company headquartered in South San Francisco, is making waves in the healthcare sector, specifically in biotechnology. With a market..

Autolus Therapeutics plc (AUTL) Stock Analysis: A Biotech Pioneer with a Staggering 354% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside of 354.43%, as per the..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 92.73% Potential Upside for Investors

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the healthcare sector under the drug manufacturers – specialty & generic industry, presents an intriguing opportunity for..

Altimmune, Inc. (ALT) Stock Analysis: Biotech’s Potential 431.55% Upside Draws Investor Attention

Altimmune, Inc. (NASDAQ: ALT), a Gaithersburg, Maryland-based biotechnology firm, has caught the eye of the investment community with its promising advancements in the healthcare sector. Specializing..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 729.88% Potential Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL), a biopharmaceutical company at the forefront of developing innovative treatments for central nervous system (CNS) disorders, presents a captivating opportunity..

MeiraGTx Holdings (MGTX) Stock Analysis: Unveiling a 125% Upside Potential for Investors

MeiraGTx Holdings plc (NASDAQ: MGTX) stands out in the biotechnology sector with a robust growth trajectory and promising clinical trials that have caught the attention of..

AxoGen, Inc. (AXGN) Stock Analysis: Healthcare Innovator with a 19% Potential Upside

AxoGen, Inc. (NASDAQ: AXGN), a trailblazer in the medical devices sector, is capturing the attention of investors with a promising potential upside of 19.02%. Headquartered in..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Capturing a Potential 181.61% Upside in the Biotech Sector

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is making waves in the biotechnology industry, with its innovative approach to targeting G protein coupled receptors (GPCRs). Headquartered in Watertown,..

Maravai LifeSciences Holdings (MRVI): Investor Outlook Reveals 2% Potential Upside Amidst Industry Growth

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a key player in the biotechnology sector, is capturing investor attention with its promising role in the ever-evolving healthcare landscape...

Valneva SE (VALN) Stock Analysis: Exploring an 86.45% Potential Upside in the Biotech Sector

Valneva SE (VALN), a prominent player in the biotechnology sector, commands attention with its strategic focus on developing and commercializing vaccines for infectious diseases with unmet..

Sana Biotechnology, Inc. (SANA) Investor Outlook: A Biotech Player with a 171.89% Upside Potential

Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing attention in the biotechnology sector with its bold ambition to revolutionize cell-based therapies. With a market capitalization of $928.02..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring a Potential 549% Upside for Investors

In the realm of biotechnology, EyePoint, Inc. (NASDAQ: EYPT) stands out with a compelling narrative for investors eyeing substantial growth potential. With a market capitalization of..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 39% Upside in the Healthcare Sector

Bioventus Inc. (NASDAQ: BVS) is garnering attention in the healthcare sector with a compelling growth narrative and a promising outlook in the medical devices industry. Headquartered..

CareDx, Inc. (CDNA) Investor Outlook: Riding High with a 52.20% Revenue Growth in the Healthcare Sector

CareDx, Inc. (CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, has captured investor attention with a remarkable 52.20% revenue growth. Based..

AtaiBeckley Inc. (ATAI) Stock Analysis: Unveiling a 10.43% Potential Upside in the Biotech Arena

AtaiBeckley Inc. (NASDAQ: ATAI) is a clinical-stage biopharmaceutical company that has caught the attention of investors with its innovative approach to mental health treatment. As a..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a Competitive Biotech Landscape with Strategic Potential

For individual investors eyeing opportunities in the biotechnology sector, Fortrea Holdings Inc. (FTRE) presents a compelling case. With a market capitalization of $1.93 billion, Fortrea stands..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 47% Upside in Regenerative Medicine

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, presents a fascinating prospect for investors keen on the healthcare industry. With its..

Zymeworks Inc. (ZYME): Investor Outlook Reveals 50% Upside Potential in Biotech Arena

For investors seeking opportunities within the dynamic biotechnology sector, Zymeworks Inc. (NASDAQ: ZYME) presents a compelling case. With a market capitalization of $1.97 billion, this Delaware-based..

Search

Funds

September 18, 2026

Search

Funds

September 18, 2026

FTSE 100

Funds